Clinuvel Pharmaceuticals Ltd (CUVL) › Free Cash FlowClinuvel Pharmaceuticals Ltd (CUVL): Free Cash FlowOperating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.$11.85MYear ended 2026-06-30$27.10M2024-06-30: $20.10M2025-06-30: $27.10M2026-06-30: $11.85M$11.85M2024-06-30 Free Cash Flow (USD) 2026-06-30Period endedFree Cash FlowChange YoYSource filing2026-06-30$11.85M-56.3%2026-10-30, From 2025-07-012025-06-30$27.10M+34.9%2026-10-30, From 2024-07-012024-06-30$20.10Mn/a2026-10-30, From 2023-07-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)